SIGNATURE TOOL · SIDE-BY-SIDE RESEARCH
Compare Peptides
Compare structured records, protocol sources, women-specific metadata and connected research without collapsing unlike evidence into one score.
VS
At a glance
| FIELD | MOTS-c | SS-31 (Elamipretide) |
|---|---|---|
| Record type | Single peptide | Single peptide |
| Research context | Mitochondrial-derived peptide | Mitochondria-targeted tetrapeptide |
| Routes indexed | Subcutaneous | Subcutaneous |
| Last reviewed | 2026-09-25 | 2026-09-25 |
Research goals
| FIELD | MOTS-c | SS-31 (Elamipretide) |
|---|---|---|
| Goal tags | Mitochondrial Health · Energy · Metabolic · Endurance · Healthy Aging · Insulin sensitivity and metabolic health · Exercise capacity and mitochondrial function · Potential healthspan support (preclinical) | Mitochondrial Health · Energy · Cellular Repair · Healthy Aging · Mitochondrial function and energy · Muscle energetics and exercise capacity · Investigational in mitochondrial myopathies and related conditions |
| Research areas | Mitochondria · Energy · Endurance · Insulin sensitivity and metabolic health · Exercise capacity and mitochondrial function · Potential healthspan support (preclinical) | Mitochondrial Health · Energy · Cellular Repair · Healthy Aging · Mitochondrial function and energy · Muscle energetics and exercise capacity · Investigational in mitochondrial myopathies and related conditions |
Protocol structure
| FIELD | MOTS-c | SS-31 (Elamipretide) |
|---|---|---|
| Variations indexed | 1 | 1 |
| Primary frequency | 3× weekly | See indexed source |
| Duration | 4 weeks | 0 weeks |
| Stage detail | COMPLETE | PENDING SOURCE EXTRACTION |
Study / reference context
| FIELD | MOTS-c | SS-31 (Elamipretide) |
|---|---|---|
| Protocol source | USER-EDITABLE PLANNING INPUT · Editable calculation context; not study data | LITERATURE-DERIVED REFERENCE · U.S. Food and Drug Administration, 2025 |
| Indexed references | 4 | 1 |
| Reference types | PRECLINICAL · REVIEW · HUMAN | REGULATORY |
Related goals
Vendors
Only current, source-verified commercial records appear here.
MOTS-c5 vendor record(s)
SS-31 (Elamipretide)No verified vendor record(s)
References
MOTS-cThe mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistancePRECLINICAL · 2015MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolismREVIEW · 2016The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivityPRECLINICAL · 2019MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasisHUMAN · 2021
SS-31 (Elamipretide)FORZINITY (elamipretide) prescribing informationREGULATORY · 2025